Replies to post #46394 on Biotech Values

[Rodenta]

about WSJ article. It's surprising the writer used the word "promising" (repeatedly) in reference to Provenge. Has this WSJ writer, like so many panel personnel, been unduly influenced by the patient-advocates he's writing about?